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EPIDERMAL CYTOPLASMIC ANTIGENS 
To the Editor: 
I would like to congratulate Bystryn, Nash and Roberts for their 
report on epidermal cytoplasmic antigens [1]. The paper was most 
interesting and has clearly explained several points that were previously 
poorly interpreted. The aim of this letter is to raise one question and to 
add 2 facts that were not available when the authors wrote the paper 
[1]. 
(I) The question 
Is the generalized cytoplasmic epidermal staining (G-CYT pattern) 
due to the concurrent presence in some sera of upper cytoplasmic 
antibodies to upper cytoplasmic antigens (U-CYT) together with basal 
cytoplasmic antibodies to basal cells antigens (BCL)? The direct re-
sponse to the question would come, I think by absorbing the sera giving 
such a G-CYT pattern either with U-CYT antigens or with BCL 
antigens. This is at present impossible because we do not know how to 
obtain U-CYT and BCL antigens. The finding of Bystryn, Nash and 
Roberts that G-CYT antigens persist in malignant lesions which, ac-
cording to their findings, do not react with sera containing antibodies 
to BCL and U-CYT "antigens," is a very important observation; it 
suggests that a G-CYT pattern is not always due to the concurrent 
presence of U-CTY and BCL antibodies in a single serum. Is this true 
for every serum giving a G-CTY pattern? 
(II) The Data 
a. Concerning the concept beautifully exposed by Bystryn, Nash and 
Roberts [1] of "cell specific maturation antigens," which is still more 
appropriate than "differentiation antigens" to qualify U-CYT and BCL 
antigens in epidermis: Our findings of distinct U-CYT and BCL speci-
ficities in orthokeratosis, parakeratosis, mucosa, [2] and even the ex-
ternal rootsheath of hairs [3] suggest that the distinct types of matu-
ration of keratinocytes are also associated with the expression of 
distinct types of "cell specific maturation antigens." 
b. Concerning the fact that some U-CYT antigens may be expressed 
in some but not all persons (1); (this was initially pubLished by Bystryn, 
Abel, and Weidman [4] and we have confrrmed this fact and demon-
strated that it was not related to HLA antigens [5]: The Table shows 
(previously unpublished data) that this is also valid for BCL antigens. 
Indirect immunofluorescence with sera obtained after bone marrow 
transplantation: not all the human skin specimens were found to react 
with the antibodies to B.C.L. antigens (Technical details in 2 and 5). 
Skin specimens from 10 human su bjects 
(1 2) (3 4) (5 6) (7 8) 9 10 
Sera with antibodies to 
B:C.L. antigens 
1 + 
2 + 
3 + + + + + + 
4 + 
6 + + + 
) indicate HLA identity-SD and MLC. 
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REPLY TO DR. SAURAT 
I wish to thank Dr. Saurat for his comments and for the additional 
data he presented indicating that there is a variation in the expression 
of BCL antigens in different individuals. We have recently observed 
similar variations in the expression of both BCL and G-CYT antigens 
and as a result, we presently believe that there are 2 subgroups of each 
type (U-CYT, G-CYT, BCL) of cytopLasmic antigen. One subgroup 
consists of antigens expressed universally in all individuals, the other 
subgroup of a family of antigens which /lfe variably expressed and are 
common to some but not all persons. It is tempting to specuLate that 
the later subgroup consists of genetically determined aLloantigens al-
though no studies have been done to estabiish this point. 
We cannot exclude at the present time that antisera to G-CYT 
antigens may not in some cases be due to the concurrent presence of 
antibodies to U-CYT and BCL antigens in the same serum. However, 
if this occurs, it is a rare phenomenon. We have reacted 10 sera positive 
for G-CYT antigens with basal cell carcinomas, which lack both BCL 
and U -CYT antigens; and in all cases still obtained positive reactions. 
This finding indicates that the G-CYT staining given by these sera was 
not due to the concurrent presence of U-CYT and BCL antibodies. 
Furthermore, BCL antibodies are found much less commonly than G-
CYT antibodies [1, 2], whereas the reverse wouLd be the case if G-CYT 
antibodies resulted from the chance association of BCL with U-CYT 
antibodies. 
Incidentally, the values of epidermal CYT antigens is that they 
provide markers that may permit more careful studies of epidermal 
differentiation. 
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